AbbVie | Liquidités



Cash And Equivalent Changement Date
AbbVie USD 5.52B 1.73B 2024-12
Abbott USD 7.62B 58M 2024-12
ALKERMES USD 291.15M 636.63M 2024-12
Amgen USD 11.97B 2.96B 2024-12
AstraZeneca USD 5.23B 258M 2025-03
Biogen USD 2.38B 675.8M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Eisai JPY 291.26B 22.65B 2024-12
Eli Lilly USD 3.27B 100.6M 2024-12
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
J&J USD 6.12B 1.28B 2024-12
Medtronic USD 1.24B 154M 2025-01
Merck USD 13.24B 1.35B 2024-12
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pacira USD 276.77M 30.81M 2024-12
Perrigo USD 558.8M 904.7M 2024-12
Pfizer USD 1.04B 49M 2024-12
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
UCB EUR 1.57B 1.14B 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
United Therapeutics USD 1.9B 202.7M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Zoetis USD 1.98B 275M 2024-12



AbbVie Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.